Townsend Letter Alternative Medicine Magazine



  FREE e-Edition


 EDTA Chelation Therapy


 E-mail List

From the Townsend Letter
February / March 2018

Supporting Healthy Estrogen Metabolism During Bioidentical Hormone Replacement Therapy
by Chris D. Meletis, ND, and Kimberly Wilkes
Search this site
Share this article...

Page 1, 2

As we grow older, an important component of any health-related regimen is the balancing of hormones to compensate for declining levels of estrogen and testosterone. Bioidentical hormone replacement therapy (BHRT) is a common and effective way to achieve this goal. However, one common mistake is to use BHRT without taking the correct dietary supplements to offset the poor metabolism of hormones. Gut health and any imbalances in the gut microbiota – the population of bacteria, fungi, and other microorganisms that inhabit the intestines – also need to be addressed to ensure the body is able to properly use estrogen and testosterone.

In this article, we will discuss the reasons why an imbalanced gut microbiota leads to dysfunctional hormone metabolism during menopause, as well as which dietary supplements are helpful in ensuring the body processes estrogen in a safe and efficient way. Finally, we will discuss why mitochondrial support is an often-neglected but critical component of bioidentical hormone replacement therapy.

The Gut as A Source Of Steroid Hormones
When considering the origin of estrogen production, the ovaries and adrenals normally come to mind. Surprisingly, however, it is now known the intestine can generate and metabolize sex hormones.1 Bioactive steroids have been identified in both the rodent and human gut.1 The cells lining the intestines (known as epithelial cells) are a cellular source of steroid production.1 In addition, intestinal epithelial cells are able to metabolize estrogen.1

17β-estradiol, a powerful estrogen made primarily by the ovaries of females and the testes of males, influences the development and function of the reproductive system. 17β-estradiol also is produced in tissues not related to reproduction where it governs a number of actions, including inflammatory responses. Lymph nodes located in a membrane that attaches the intestine to the abdominal wall and lymphatic tissue in the small intestine produce 17β-estradiol.2 In mice, these intestinal lymphatic areas contained 17β-estradiol levels significantly greater than those in blood, and there was more 17β-estradiol in lymph-related organs compared with the ovaries and testes.2

The estrogen estradiol also protects the lining of the intestines known as the epithelial barrier from damage.3 It keeps the gut walls strong and stops "leaky gut," what scientists call intestinal permeability, where bacteria and food allergens slip through a weak intestinal lining and out into the blood stream, where they can wreak havoc in the body.3

Further evidence of a link between estrogen and the gut comes in the form of studies that show there is a relationship between estrogen and inflammatory bowel syndrome (IBS).4 Estrogen helps regulate the development of IBS in part through its ability to interact with the hormone serotonin,4 a large amount of which is produced in the gut and helps regulate intestinal function. Estrogen also reduces the effect of psychological stress on the brain and the gut.4 Some studies have found that, while in postmenopausal women, there is a significant decrease in incidence of IBS,5 symptom severity may increase following menopause.6

SUPPORTTownsend Letter provides a platform for those examining and reporting on functional and integrative medicine. Please support these independent voices.

Estrogen and Your Gut Bacteria
The beneficial microbes in a woman's gut are affected by age and her declining estrogen levels.7 But the relationship between the gut microbiota and estrogens is a two-way street because the gut microbiota also help regulate levels of estrogens.7

The parent estrogens estrone and estradiol are metabolized in several ways including the 2-, 4-, and 16-hydroxylation pathways. Each of these estrogen metabolites differs in how easily they are used by the body and the strength of the metabolite. And each of these estrogen metabolites has different effects on the body. In many cell culture and animal studies, a higher level of 2-hydroxylated estrogen metabolites is associated with a lower risk of postmenopausal breast cancer. The gut microbiota may play an important role in assuring that estrogen is metabolized through the safer 2-hydroxylated pathway. One group of researchers found that in 60 postmenopausal women, greater diversity of the microbiota was associated with higher ratios of 2- and 4-hydroxylated metabolites to parent estrogens such as estrone and estradiol, suggesting that gut microbes are associated with estrogen metabolism and optimal counts of beneficial bacteria may reduce postmenopausal breast cancer risk.7

Researchers also have shown that the use of conventional estrogen replacement therapy is able to boost levels of beneficial vaginal bacteria.8 In one study of 40 postmenopausal women receiving hormone replacement therapy (HRT) and 20 who were not on HRT, the probiotic species lactobacilli were present in the vagina of 95% or more of the participants in both groups.8 However, in the HRT group, Lactobacillus was more often the dominant and only beneficial species present. In addition, in the HRT group, there were significantly fewer harmful bacteria. Plus, an infection known as bacterial vaginosis occurred less often in the HRT group compared with the women not receiving HRT.

Adding to the evidence that there is a connection between steroid hormones and the gut is the fact that the probiotic organism Lactobacillus reuteri when given to mice in their drinking water, improved markers of gonadal aging.9 The study authors believe this was due to the anti-inflammatory actions of the probiotic. Even though this study was done in male mice, it provides an interesting perspective that could be applied in clinical practice to females.

Klaire LabsThe Microbiota's Far-Reaching Role in Postmenopausal Health
Declining estrogen levels during menopause makes women more vulnerable to increased bone loss and fracture risk.10,11 The microbiota are involved in protecting against age-related bone loss. In mouse models of menopause, supplementation with the probiotic L. reuteri stopped bone loss and reduced bone breakdown related to estrogen deficiency.12

The way the gut microbiota accomplishes its bone-protecting effects is in part through raising levels of insulin-like growth factor 1 (IGF-1), which plays a role in bone health.13 Clinically, IGF-1 also serves as a marker of biological aging and growth hormone levels.14,15 The lower your IGF-1, the lower your growth hormone levels and the faster you age and suffer from effects like cognitive decline.15

Phytoestrogen Supplements and Gut Bacteria
Menopausal women commonly use phytoestrogen supplements to ease symptoms such as hot flashes. Phytoestrogens such as soy have a similar chemical structure to human estrogens, produce estrogenic activities, and cause effects similar to estrogen. Intestinal bacteria metabolize phytoestrogens into compounds that are more bioavailable and have more estrogenic/anti-estrogenic and antioxidant activity than the parent phytoestrogens themselves.16,17 These compounds also have anti-inflammatory effects, stop the multiplication of cells, which is linked to cancer, and trigger the death of unhealthy cells.17,18

Some individuals have the ability, through the actions of the intestinal microbiota, to convert phytoestrogens into these more bioavailable metabolites, which may make them less vulnerable to hormone-dependent diseases.19-21 The intestinal microbiota's transformation of phytoestrogens into their bioavailable metabolites is critical to the reduction of menopausal symptoms and certain chronic diseases, such as cancer, cardiovascular disease, and osteoporosis.19-21

One group of researchers suggested, "the clinical effectiveness of soy protein in cardiovascular, bone, and menopausal health may be a function of the ability to biotransform soy isoflavones to the more potent estrogenic isoflavone, equol" and that this transformation was dependent on intestinal bacteria.22 The researchers pointed out that past studies did not distinguish between participants who were "equol-producers" and "nonequol producers," which could explain why studies on the health benefits of soy have yielded conflicting results.

The Importance of Blocking a Harmful Enzyme
The body processes hormones as well as drugs and environmental toxins using a sugar called glucuronic acid. In the liver, this sugar attaches itself to drugs, hormones, and toxins meant to be excreted from the body through the bile duct to the GI tract. In doing so, glucuronic acid neutralizes the potentially harmful substance. However, an enzyme called beta-glucuronidase searches for this sugar because it needs to use it as a source of carbon. Once beta-glucuronidase separates the glucuronic acid from the hormone, toxin, or drug, metabolites of these substances are not always completely eliminated from the body.23 They can be reactivated and highly toxic to GI tissues.23 That's why it is essential that beta-glucuronidase levels be balanced in people on BHRT, so that estrogen does not become reabsorbed.

A small number of the thousands of intestinal microbiota organisms – about 50 species, including E. coli – can release beta-glucuronidase.24 On the other hand, a number of probiotic organisms can inhibit the production of beta-glucuronidase. A study of the fecal water of 15 people who were a variety of ages (children, adults, and elderly) found that when the water was incubated with a carcinogen, the toxicity and the beta-glucuronidase activity of the water was increased.25 However, the probiotic organism Lactobacillus paracasei reduced beta-glucuronidase by 76% in the fecal water of the children and by 82% in the elderly.

Another study investigated the effects of a multispecies probiotic supplement consisting of Lactobacillus rhamnosus GG, Lactobacillus rhamnosus Lc705, Propionibacterium freudenreichii ssp. shermanii JS, and Bifidobacterium breve on intestinal microbiota and beta-glucuronidase in patients with irritable bowel syndrome (IBS).26 In this placebo-controlled, double-blind trial, 55 IBS patients received either the multispecies probiotic or a placebo daily for six months. At the study's conclusion, researchers observed a decline in beta-glucuronidase activity in 67% of the subjects given the probiotic compared with only 38% of participants given the placebo.

In an animal study, rodents that were exposed to one of three conditions – a chemical that causes colon cancer, atherosclerosis triggered by a high-fat diet, or an imbalance of the gut microbiota caused by antibiotic administration – were supplemented daily with Lactobacillus plantarum alone or combined with antibiotics.27 In the rats exposed to the cancer-causing chemical, the probiotic lowered beta-glucuronidase activity. In the atherosclerosis group and the imbalanced gut microbiota rodents, combining the probiotic with an antibiotic also reduced beta-glucuronidase activity.

Calcium D-Glucarate
Calcium-D-glucarate is the calcium salt of D-glucaric acid, which humans synthesize naturally in small amounts. Many fruits and vegetables, especially oranges, apples, grapefruit, and cruciferous vegetables, are also a source of glucaric acid. Oral supplementation of calcium D-glucarate blocks the beta-glucuronidase enzyme for five hours.28

Calcium-D-glucarate's ability to suppress beta-glucuronidase helps hormones such as estrogen to be excreted before they are reabsorbed. Large oral doses of calcium-D-glucarate fed to rats resulted in a 23% drop in serum estrogen levels.28 In rats exposed to a chemical carcinogen that causes breast cancer in the animals, calcium D-glucarate blocked tumor development by over 70%.29

Scientists have also studied calcium-D-glucarate in breast, lung, colon, and liver cancers in rodent models, and the beneficial results occurred due to a variety of mechanisms including inhibiting beta-glucuronidase activity.28,30,31

Because calcium D-glucarate blocks beta-glucuronidase and therefore improves the excretion of estrogen from the body, Dr. Meletis uses it in his clinical practice in patients on estrogen replacement therapy as a precaution against estrogen re-absorption and the resulting harmful effects.

Page 1, 2

Consult your doctor before using any of the treatments found within this site.

Subscriptions are available for Townsend Letter, the Examiner of Alternative Medicine
magazine, which is published 10 times each year. Search our pre-2001 archives for further information. Older issues of the printed magazine are also indexed for your convenience.
1983-2001 indices ; recent indices. Once you find the magazines you'd like to order, please
use our convenient form, e-mail, or call 360.385.6021.


Fax: 360.385.0699

Who are we? | New articles | Featured topics | e-Edition |
Tables of contents
| Subscriptions | Contact us | Links | Classifieds | Advertise |
Alternative Medicine Conference Calendar | Search site | Archives |
EDTA Chelation Therapy | Home

© 1983-2018 Townsend Letter
All rights reserved.
Website by Sandy Hershelman Designs